BridgeBio Oncology Therapeutics (BBOT)
0 followers
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financ... Read more
Org chart
Eli Wallace
Chief Executive Officer
Eli Wallace
Collapse
Pedro J. Beltran
Chief Scientific Officer
Howard Chang
Vice President, Operations
Raymond Kelleher
Director
Scott Platshon
Board Observer
Similar companies
Tessera Therapeutics
2 followers
Vaxcyte
2 followers
Vera Therapeutics
2 followers
Day One Biopharmaceuticals
1 follower
QurAlis
1 follower
Aura Biosciences
1 follower
MedRhythms
1 follower
Amgen
181 followers
Astria Therapeutics
1 follower
Thermo Fisher Scientific
141 followers
Genentech
143 followers
Discover companies